Trading

Data

Solutions

Insights

908 Devices Stock

908devices.comHealthcareFounded: 2012Funding to Date: $74MM

908 Devices is the designer and manufacturer of point-of-need chemical analysis devices ranging from rugged, handheld chemical detection tools to compact, tiny footprint analyzers and fast separation devices.

Learn more about 908 Devices IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

View Enterprise Value for 908 Devices.

Register Today

Team

Management Team

Joseph Griffith

Chief Financial Officer

Scott Miller Ph.D

Co-Founder & Director, Mass Spectrometer Engineering

Christopher Brown

Co-Founder, Chief Technology Officer & Vice President

Michael Jobin

Co-Founder & Director Product Development

Kevin Knopp Ph.D

Co-Founder, Chief Executive Officer, President & Board Member

Andy Bartfay

Co-Founder & Director of Hardware Development

Steve Araiza

Co-Founder and Director of Software

Board Members

Keith Crandell

ARCH Venture Partners

Sharon Kedar

Northpond Ventures

J. Michael Ramsey Ph.D

Nicolas Barthelemy

Kevin Hrusovsky

Mark Spoto JD

Razor's Edge Ventures

Other companies like 908 Devices in the Healthcare sector

Neuralink

Sector

Healthcare

Last Round Est. Valuation

$2.15B

Sector

Sector

Last Round Est. Valuation

$3.67B

Synchron

Sector

Healthcare

Last Round Est. Valuation

$400.53MM

Grail

Sector

Healthcare

Last Round Est. Valuation

$4.26B

Sector

Sector

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Healthcare

News

Genomeweb 11/11/2021

908 Devices Prices $100M Public Offering

The company priced a public offering of 3,150,000 shares of its common stock at $32.00 per share that is expected to gross approximately $100.8 million.

Popular Topics

Popular Topics

908 Devices Stock

Register for Details